Charts looked exactly the same on Friday. Was up 10% at this time, then up 56% by the close. Aegis Capital targeted CPRX at $2.50. Zacks has rated this as #1. Financials are there, drug trials doing well, etc. This only has up to go. The only way to find negative news on this bull is if you made it up.